Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer
The Prostate · 2026
DOI: 10.1002/pros.70256 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2026. Verfasst von Zhihua Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Transcriptome. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
We sought to characterize an LHB‐associated tumor transcriptomic state across public prostate cancer datasets. Tumor LHB expression and the correlation‐derived signature were treated as molecular measurements only; serum luteinizing hormone and testosterone were not available or analyzed.
Methods
In 501 TCGA‐PRAD tumors, the 25 genes most positively and 25 most negatively correlated with LHB defined a direction‐weighted signature. The frozen score was projected without refitting into GSE54460, GSE116918, and two GSE21034 platform views. Cohort‐specific grade, biochemical recurrence, and compact expression programs were evaluated. Program genes did not overlap the signature, and LHB was excluded from steroidogenesis. In GSE176031, upper and lower signature‐score quartiles were compared within each of 53 samples.
Results
The score was higher in high‐grade TCGA‐PRAD tumors (mean difference, 0.327; P = 7.12 × 10 −9 ) and had positive but heterogeneous grade differences in the external datasets. Across all five bulk views, the score correlated negatively with androgen receptor signaling ( r = −0.365 to −0.627) and positively with cell cycle ( r = 0.283–0.692) and epithelial‐mesenchymal transition ( r = 0.217–0.734). Direct LHB transcripts were detected in 30 of 53,765 cells. Sample‐level single‐cell contrasts showed lower androgen receptor signaling and higher cell‐cycle and epithelial‐mesenchymal‐transition scores in signature‐high epithelial states; the LHB‐excluded steroidogenesis contrast was near zero.
Conclusions
The LHB‐correlation‐derived signature identifies an AR‐low, proliferative, mesenchymal‐associated expression state across datasets. It does not measure circulating hormones, establish LHB‐dependent biology, or support clinical use. Paired molecular and functional studies are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Urology, Dongtai People's Hospital, Dongtai, Jiangsu, China.
ORCID-Profile: Zhihua Pan, Jinjiang Fan, Ruizhe Zhao, Bianjiang Liu
Zitieren
APA
Pan, Z., Fan, J., Zhang, L., Zhao, R., Zhang, S., Li, J., & Liu, B. (2026). Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer. The Prostate. https://doi.org/10.1002/pros.70256
Vancouver
Pan Z, Fan J, Zhang L, Zhao R, Zhang S, Li J, et al. Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer. The Prostate. 2026. doi:10.1002/pros.70256
BibTeX
@article{Pan2026,
author = {Pan, Zhihua and Fan, Jinjiang and Zhang, Lidian and Zhao, Ruizhe and Zhang, Shaobo and Li, Jie and Liu, Bianjiang},
title = {Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer},
journal = {The Prostate},
year = {2026},
doi = {10.1002/pros.70256}
}
EUVIMED